Home >  News >  June, 2014

FDA Says More Decisions on Morcellation Coming

The agency will hold a public meeting in July.

Published: June 12, 2014

Will morcellation devices used to laparoscopically remove uterine fibroids be recalled or banned? The FDA is convening a meeting next month to take up the topic.

The agency issued an advisory in April, discouraging their use because the devices can spread cancerous tissue in women with undetected uterine sarcomas, a condition the agency says may affect as many as 1 in every 350 women.

However, proponents of morcellation say the proportion of women with undetected sarcomas is likely closer to 1 in 1,000; that the prognosis is already bleak for those women; and that for everyone else, the alternatives are typically much more dangerous and invasive.

The FDA's Medical Devices Advisory Committee will hold a public meeting on July 10 and 11 and plans to "make recommendations regarding the appropriate use, premarket testing, labeling, and other risk mitigations" for morcellators.

One stock analyst, Greg Chodaaczek of Sterne Agee, says the meeting is likely to result in a so-called black-box warning, saying he doesn't think there's enough data to warrant a recall or ban.

Jim Burger


Also in the News...

Do Drug-Free Interventions Reduce Pain or Opioid Consumption After Total Knee Arthroplasty?
Administration Signals Likely End to Medicare Bundled Payments Initiative
New Program Aims to Optimize Colorectal Surgery
Hospital Accused of Elaborate Cover-Up After Unnecessary Surgery
Robotic Device Shows Promise as Soft, Smart Endoscope Tool
Penis Enhancement Surgery Turns Fatal
Sterility Concerns Prompt Shutdown of Utah-Based Compounding Pharmacy

New to Outpatient Surgery Magazine?
Sign-up to continue reading this article.
Register Now
Have an account? Please log in:
Email Address:
  Remember my login on this computer

advertiser banner

Other Articles That May Interest You

Nurse Admits to Texting Photo of Unconscious Patient's Penis

She lost her job and her license after coworkers complained.

As Business Boomed at Compounding Pharmacy, Disinfection Practices Slid

At meningitis trial, pharmacy tech testifies that hoods in clean room where tainted steroids were made weren't disinfected for a month.

Docs Who Get Sued Likely Will Be Sued Again